# Heme Arginate in Transplantation Study

> **NCT03646344** · PHASE3 · TERMINATED · sponsor: **University of Edinburgh** · enrollment: 47 (actual)

## Conditions studied

- Renal Transplant Rejection
- Renal Transplant Failure

## Interventions

- **DRUG:** Heme Arginate 25 MG/ML
- **DRUG:** 0.9% Sodium-chloride

## Key facts

- **NCT ID:** NCT03646344
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-12
- **Primary completion:** 2020-03-17
- **Final completion:** 2021-02-23
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** COVID
- **Last updated:** 2025-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03646344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03646344, "Heme Arginate in Transplantation Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03646344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*